why choose us

First received: November 19, 2024

Clinical Trial: Post-registration Trial of the Non-immunogenic Staphylokinase in Acute Ischemic Stroke (FORPI Registry)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Acute Ischemic Stroke

Study Type: OBSERVATIONAL


Official Title: An Open, Prospective, Non-interventional, Multicentre, Controlled Study of Safety and Efficacy of the Thrombolysis With the Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke (FORPI

Brief Summary: The aim of FORPI Registry is to study the safety and efficacy of the non-immunogenic staphylokinase in patients with acute ischemic stroke in routine clinical practice.

Read more